We are international
Donate
publications TEXT SIZE   
general information

A Phase II Study of Velcade, Doxil, and Thalidomide (VDT) in Relapsed/Refractory Myeloma
By Asher A. Chanan-Khan, MD
12.18.06
A Phase II Study of Velcade, Doxil, and Thalidomide (VDT) in Relapsed/Refractory Myeloma



 related articles